Consolidated Statements of Cash Flows
(Millions of yen)
| Year ended March 31, 2019 |
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
Year ended March 31, 2023 |
Year ended March 31, 2024 |
|
|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||
| Profit for the period | 54,044 | 7,823 | 30,995 | 92,302 | 75,051 | 52,620 |
| Depreciation and amortization | 56,137 | 68,416 | 69,852 | 64,595 | 68,696 | 68,682 |
| Impairment loss and reversal of impairment loss | 743 | 581 | 7,823 | 1,460 | 1,966 | 1,339 |
| Finace (income) costs | (585) | (156) | 2,820 | (2,569) | (6,604) | (12,537) |
| Share of (profit) loss of investments accounted for using the equity method | (99) | (77) | (99) | (113) | (105) | (23) |
| Loss (gain) on sales and disposal of property, plant and equipment, intangible assets and investment property | (3,221) | 672 | 316 | 232 | (716) | 532 |
| Income taxes | 17,995 | 31,889 | 13,937 | 4,859 | 28,703 | 17,473 |
| Decrease (increase) in trade receivables | (4,750) | 12,407 | (1,004) | 3,006 | (22,131) | 4,370 |
| Decrease (increase) in inventories | (24,915) | 9,224 | (12,865) | (28,230) | (60,253) | 71,097 |
| Increase (decrease) in trade payables | (6,826) | (11,420) | 13,151 | 2,175 | (1,645) | (7,921) |
| Increase (decrease) in net defined benefit liabilities | 1,663 | 1,863 | 2,888 | 1,532 | (799) | 663 |
| Other | 3,473 | (10,136) | 14,779 | (6,428) | 11,100 | (10,957) |
| Subtotal | 93,659 | 111,088 | 142,595 | 132,823 | 93,260 | 185,340 |
| Interest and dividend income received | 2,055 | 2,084 | 1,365 | 1,470 | 3,339 | 4,931 |
| Interest expenses paid | (1,164) | (1,181) | (1,111) | (1,071) | (1,208) | (1,821) |
| Payments for loss on litigation | - | - | - | - | - | - |
| Proceeds from insurance income | - | 2,614 | 339 | - | - | - |
| Income taxes paid | (17,588) | (12,281) | (9,966) | (22,420) | (34,080) | (22,879) |
| Net cash provided by (used in) operating activities | 76,961 | 102,324 | 133,222 | 110,801 | 61,311 | 165,570 |
| Cash flows from investing activities | ||||||
| Purchase of investment securities | (900) | (1,041) | (297) | (747) | (827) | (1,371) |
| Proceeds from sales of investment securities | 2,144 | 25 | 26 | 622 | 154 | 1,004 |
| Purchase of property, plant and equipment | (79,858) | (65,250) | (47,504) | (38,602) | (50,551) | (49,570) |
| Proceeds from sales of property, plant and equipment | 9,313 | 840 | 467 | 245 | 1,058 | 404 |
| Purchase of intangible assets | (10,445) | (10,457) | (8,371) | (5,242) | (8,545) | (7,023) |
| Proceeds from sales of intangible assets | 13 | 14 | 21 | 33 | 21 | 15 |
| Proceeds from sales of investment property | 22 | 16 | - | 352 | 1,985 | - |
| Purchase of investments in subsidiaries | (887) | - | - | - | - | - |
| Other | (2,142) | (280) | (1,790) | (746) | (4,897) | (2,440) |
| Net cash provided by (used in) investing activities | (82,738) | (76,131) | (57,448) | (44,083) | (61,602) | (58,981) |
| Cash flows from financing activities | ||||||
| Net increase (decrease) in current borrowings | (16,832) | (9,816) | (889) | - | 9 | 502 |
| Proceeds from non-current borrowings | - | 29,948 | - | 500 | - | - |
| Repayments of non-current borrowings | (135) | - | (14,000) | (500) | (18,000) | - |
| Proceeds from issuance of bonds issued | - | 29,846 | 69,676 | - | - | - |
| Redemption of bonds issued | (10,000) | (10,000) | - | (20,000) | - | (30,000) |
| Payments of lease obligations | (150) | (8,203) | (9,667) | (8,275) | (10,003) | (10,033) |
| Dividends paid | (22,190) | (21,646) | (21,449) | (21,451) | (21,313) | (25,862) |
| Dividends paid to non-controlling interests | (120) | (188) | (519) | (394) | (0) | (0) |
| Payments for purchase of subsidiaries' equity from non-controlling interests | - | - | - | (1,648) | - | - |
| Purchase of treasury shares | (0) | (10,224) | (1) | (1) | (30,042) | (1) |
| Net cash provided by (used in) financing activities | (49,430) | (283) | 23,150 | (51,771) | (79,349) | (65,395) |
| Effect of exchange rate changes on cash and cash equivalents | 767 | (4,901) | 8,837 | 16,285 | 11,781 | 19,907 |
| Net increase (decrease) in cash and cash equivalents | (54,439) | 21,007 | 107,761 | 31,232 | (67,859) | 61,100 |
| Cash and cash equivalents at beginning of period | 229,678 | 175,238 | 196,245 | 304,007 | 335,239 | 267,380 |
| Cash and cash equivalents at end of period | 175,238 | 196,245 | 304,007 | 335,239 | 267,380 | 328,481 |
Official Account
